Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1976 May 15;125(2):244-8.
doi: 10.1016/0002-9378(76)90601-3.

An Evaluation of the Teratogenicity of Certain Antinauseant Drugs

Clinical Trial

An Evaluation of the Teratogenicity of Certain Antinauseant Drugs

L Milkovich et al. Am J Obstet Gynecol. .

Abstract

In a large, prospective, observational study of pregnancy and child development, the antinauseant drugs prescribed to gravides for nausea and vomiting in the first 84 days of pregnancy were evaluated for their teratogenic potential. The severe congenital anomaly rates per 100 liveborn children and ther perinatal death rates of this group did not differ from the rates of the group with untreated nausea and vomiting. There was no indication that the phenothiazine derivatives, specifically the prochlorperazine derivative, as well as meclizine, cylizine, and Bendectin were associated with teratogenicity. The trimethobenzamide drug gave a slight suggestion of an excess of severe congenital anomalies.

Similar articles

See all similar articles

Cited by 25 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback